Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/1/25 16:30 | 7/30/25 | NUVL | Health | Drug | Pharmaceutical Preparations | Noci Darlene | MA | O | Chief De | 3 | S.d | -922 | 76.79 | 0 | -12 | 48 | D | |||||||||||||||
7/17/25 16:32 | 7/15/25 | NUVL | Health | Drug | Pharmaceutical Preparations | Balcom Alexandra | MA | O | CFO | 2 | S.dm | -3,294 | 82.35 | 0 | -40 | 62 | D | |||||||||||||||
7/17/25 16:31 | 7/15/25 | NUVL | Health | Drug | Pharmaceutical Preparations | Porter James Richard | MA | DO | P,CEO | 3 | S.d | -6,178 | 76.27 | 0 | -81 | 249 | D | |||||||||||||||
7/11/25 16:30 | 7/9/25 | NUVL | Health | Drug | Pharmaceutical Preparations | Pelish Henry E. | MA | O | Chief Sc | 3 | S.dm | -1,493 | 80.06 | 0 | -19 | 63 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |